Tactic Gem LLC is > 10% Shareholder of Monopar Therapeutics. Currently has a direct ownership of 0 shares of MNPR, which is worth approximately $0. The most recent transaction as insider was on Dec 09, 2024, when has been sold 1,433,334 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

TacticGem LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2024
SELL
Other acquisition or disposition
-
1,433,334 Reduced 100.0%
0 Common Stock
TL

Tactic Gem LLC

> 10% Shareholder
Lake Forest, IL

Track Institutional and Insider Activities on MNPR

Follow Monopar Therapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNPR shares.

Notify only if

Insider Trading

Get notified when an Monopar Therapeutics insider buys or sells MNPR shares.

Notify only if

News

Receive news related to Monopar Therapeutics

Track Activities on MNPR